CN102203130B - Glp-1衍生物及其应用 - Google Patents
Glp-1衍生物及其应用 Download PDFInfo
- Publication number
- CN102203130B CN102203130B CN201180000352.1A CN201180000352A CN102203130B CN 102203130 B CN102203130 B CN 102203130B CN 201180000352 A CN201180000352 A CN 201180000352A CN 102203130 B CN102203130 B CN 102203130B
- Authority
- CN
- China
- Prior art keywords
- compound
- diabetes
- application
- type
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *CC[C@](C(OCc1ccccc1)=O)N Chemical compound *CC[C@](C(OCc1ccccc1)=O)N 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201180000352.1A CN102203130B (zh) | 2010-08-06 | 2011-04-29 | Glp-1衍生物及其应用 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010246866.2 | 2010-08-06 | ||
CN201010246866 | 2010-08-06 | ||
CN201110078528.7 | 2011-03-30 | ||
CN201110078528 | 2011-03-30 | ||
PCT/CN2011/000765 WO2012016419A1 (zh) | 2010-08-06 | 2011-04-29 | Glp-1衍生物及其应用 |
CN201180000352.1A CN102203130B (zh) | 2010-08-06 | 2011-04-29 | Glp-1衍生物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102203130A CN102203130A (zh) | 2011-09-28 |
CN102203130B true CN102203130B (zh) | 2014-06-25 |
Family
ID=44662767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180000352.1A Active CN102203130B (zh) | 2010-08-06 | 2011-04-29 | Glp-1衍生物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102203130B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111410687B (zh) * | 2020-02-21 | 2023-06-27 | 成都奥达生物科技有限公司 | 一种长效glp-1化合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1862450A2 (en) * | 2002-07-10 | 2007-12-05 | Karo Bio Ab | Novel compounds |
WO2009083549A1 (en) * | 2007-12-28 | 2009-07-09 | Novo Nordisk A/S | Semi-recombinant preparation of glp-1 analogues |
CN101565429A (zh) * | 2004-02-23 | 2009-10-28 | 塔夫茨大学信托人 | 调节葡萄糖代谢的二肽基肽酶ⅳ抑制剂 |
-
2011
- 2011-04-29 CN CN201180000352.1A patent/CN102203130B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1862450A2 (en) * | 2002-07-10 | 2007-12-05 | Karo Bio Ab | Novel compounds |
CN101565429A (zh) * | 2004-02-23 | 2009-10-28 | 塔夫茨大学信托人 | 调节葡萄糖代谢的二肽基肽酶ⅳ抑制剂 |
WO2009083549A1 (en) * | 2007-12-28 | 2009-07-09 | Novo Nordisk A/S | Semi-recombinant preparation of glp-1 analogues |
Non-Patent Citations (2)
Title |
---|
EPEP1862450A2A2 2007.12.05 |
WOWO2009083549A1A1 2009.07.09 |
Also Published As
Publication number | Publication date |
---|---|
CN102203130A (zh) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102186881B (zh) | 胰高血糖素样肽-1衍生物及其应用 | |
EP2565205B1 (en) | Glucagon-like peptide-1 analogue and use thereof | |
JP7491610B2 (ja) | エキセナチド類似体 | |
JP7432361B2 (ja) | ヒトインスリンまたはそのアナログのアシル化誘導体 | |
KR20220066148A (ko) | Glp-1 화합물 | |
KR20210005630A (ko) | 글루코스-반응성 인슐린 | |
CN105143183A (zh) | 联芳基取代的4-氨基丁酸衍生物及其制备方法和用途 | |
CN110437329B (zh) | 口服降糖肽、其脂肪酸衍生物及用途 | |
CN102229668A (zh) | 一种glp-1衍生物及其应用 | |
CN108948212B (zh) | 长效化胃泌酸调节素(oxm)杂合肽及其制备方法与应用 | |
CN108822222B (zh) | 一种长效化降糖减重肽,及其制备方法与应用 | |
CN102203130B (zh) | Glp-1衍生物及其应用 | |
WO2012016419A1 (zh) | Glp-1衍生物及其应用 | |
CN107056926A (zh) | 一类带有醚键的艾塞那肽(Exendin-4)类似物及其应用 | |
CN104672210A (zh) | 阿格列汀和苯甲酸阿格列汀的制备方法 | |
CN108948213B (zh) | 长效化胃泌酸调节素(oxm)杂合肽、其制备方法及其作为药物的用途 | |
JP5871905B2 (ja) | グルカゴン様ペプチド−1類似体およびその使用 | |
CN107298708A (zh) | 一种带有醚键的胰高血糖素样肽-1(glp-1)类似物及其应用 | |
CN115594752A (zh) | 一种长效双激动剂化合物 | |
CN116496361B (zh) | 氘代模拟肽gip和glp-1双受体激动剂药物及用途 | |
CN116574169B (zh) | 氘代gip/glp-1/gcg多受体激动剂药物及用途 | |
CN115960258B (zh) | 一类GLP-1/glucagon/Y2受体三重激动剂及其应用 | |
CN112826821A (zh) | 别嘌呤醇类衍生物在制备预防和/或治疗糖尿病的药物中的用途 | |
CN115368344A (zh) | 组氨酸类衍生物及其制备方法和应用 | |
CN103709149A (zh) | 托西酸贝格列汀晶型及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1162526 Country of ref document: HK |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 311100 No. 589 Hongfeng Road, Yuhang Economic Development Zone, Zhejiang, Hangzhou, China Applicant after: Beta Pharmaceutical Co., Ltd. Address before: 311100 No. 589 Hongfeng Road, Yuhang Economic Development Zone, Zhejiang, Hangzhou, China Applicant before: Zhejiang Beta Pharmacy Inc. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: ZHEJIANG BETA PHARMA CO., LTD. TO: BETA PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1162526 Country of ref document: HK |